Close Menu

NEW YORK (360Dx) – Singapore cancer diagnostics firm Clearbridge BioMedics said today that it has secured S$6.6 million ($4.8 million) in funding ahead of a planned initial public offering.

According to the company, the round drew interest from both biotech investors, and from medical professionals in the oncology space. Money raised will support Clearbridge's business expansion, technology development, talent recruitment, and expenses related to its potential listing.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.

Noel Rose, the "father of autoimmunity," has died at 92, the Washington Post reports.

According to CNN, Legionella was discovered in buildings leased by the Centers for Disease Control and Prevention as they reopened following coronavirus pandemic-related closures.

In PLOS this week: genetic analysis of malaria parasite populations in Southeast Asia, genomic surveillance of yellow fever virus in São Paulo, and more.